Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Aeglea BioTherapeutics Inc..
Aeglea BioTherapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Aeglea BioTherapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Aeglea BioTherapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Aeglea BioTherapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Aeglea BioTherapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Aeglea BioTherapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Aeglea BioTherapeutics Inc.- Key Facts
2.2 Aeglea BioTherapeutics Inc.- Geographic Locations
2.3 Aeglea BioTherapeutics Inc.- Subsidiaries and Affiliates
2.4 Aeglea BioTherapeutics Inc.- Business Divisions
2.5 Aeglea BioTherapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Aeglea BioTherapeutics Inc. Strategic Analysis Review
3.1 Aeglea BioTherapeutics Inc.- Key Strategies
3.2 Aeglea BioTherapeutics Inc.- Company Outlook Statement
3.3 Aeglea BioTherapeutics Inc.- SWOT Analysis
3.3.1 Aeglea BioTherapeutics Inc.- Key Strengths
3.3.2 Aeglea BioTherapeutics Inc.- Key Weaknesses
3.3.3 Aeglea BioTherapeutics Inc.- Potential Opportunities
3.3.4 Aeglea BioTherapeutics Inc.- Potential Threats
3.4 Aeglea BioTherapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Aeglea BioTherapeutics Inc.- Business Overview
4.2 Aeglea BioTherapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Aeglea BioTherapeutics Inc.- Key Products
5.2 Aeglea BioTherapeutics Inc.- Key Service Areas
5.3 Aeglea BioTherapeutics Inc.- Key Brands
6 Company Developments
6.1 Aeglea BioTherapeutics Inc.- Company History
6.2 Aeglea BioTherapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Aeglea BioTherapeutics Inc.- Income Statements
7.2 Aeglea BioTherapeutics Inc.- Balance Sheet
7.3 Aeglea BioTherapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Aeglea BioTherapeutics Inc.- Direct Competitors
8.2 Aeglea BioTherapeutics Inc.- Competitor Financial Ratios comparison
8.3 Aeglea BioTherapeutics Inc.- Competitor Stock Charts Comparison
8.4 Aeglea BioTherapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 70%
$100- 50%
$200- 50%
$100- 50%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 837 45 77855
- sales@swotreports.com
-
Chat on WhatsApp
